February 2017: Spironolactone - potion or poison?
Episode 73 of the DTB Podcast podcast, hosted by BMJ Group, titled "February 2017: Spironolactone - potion or poison?" was published on February 6, 2017 and runs 14 minutes.
February 6, 2017 ·14m · DTB Podcast
Summary
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the risk of hyperkalaemia associated with spironolactone in people with heart failure. They consider recent advice issued by the Medicines and Healthcare products Regulatory Agency and highlight the importance of regular monitoring of potassium and renal function. The editors also review the evidence for daclizumab, a drug for relapsing multiple sclerosis, and provide a brief introduction to the rationale and methods of qualitative research in health care.
Episode Description
The editors also review the evidence for daclizumab, a drug for relapsing multiple sclerosis, and provide a brief introduction to the rationale and methods of qualitative research in health care.
Similar Episodes
Jun 9, 2020 ·13m
Jun 9, 2020 ·15m
Jun 4, 2020 ·11m
May 27, 2020 ·35m
Aug 15, 2016 ·23m
Jul 15, 2016 ·21m